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Introduction
From a synthetic point of view, 4-oxo-4H-chromene and coumarin derivatives are versatile synthons for synthesis of a diverse set of rearranged products and new heterocyclic systems [1, 2] . Many chromene and coumarin derivatives exhibit a broad spectrum of biological properties, such as antitumour [3] , antibacterial [4] or antiviral [5] . In addition, several chromene derivatives have been identified in angiogenesis [6] and also as selective estrogen receptor modulators [7] . Moreover, coumarins are also known for their important photochromic characteristics [8] . Synthetic exploitation of 4-oxo-4H-chromen-3-carbaldehyde 1 and its derivatives results from their reactivity towards nucleophiles. The presence of three electrophilic centers in the molecule 1 and the ability to open or retain the pyrone ring [9, 10] can give access to a wide variety of heterocycles [11, 12] . Because 4-oxo-4H-chromenes and coumarins have found many applications in medicine [13, 14] , the synthesis of new types of chromene derivatives is therefore of high interest.
The present study is a follow-up paper to the previous articles dealing with the synthesis, kinetics, theoretical and photochemical properties and biological activity of several series of chromene derivatives [15] [16] [17] .
The aim of this study was to determine the reaction conditions for coupling two chromene (4-oxo-and 2-oxo-) moieties 1, 2 in one skeleton under conditions different to Doebner reaction in order to synthesize new potential
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Synthesis, reactions and antineoplastic activity of 3-(2-oxo-2H-chromen-3-yl)-2-oxo-2H,5H-pyrano [3,2-c] chromene derivatives anticancer compounds. Our research was based on recently discovered antitumour properties of 2-oxo-2H,5H-pyrano [3,2-c] chromene skeleton [18] .
Experimental procedure
Melting points were determined on a Kofler hot plate apparatus and are uncorrected. 1 H NMR / 13 C NMR spectra were obtained on a 300 MHz / 75 MHz VARIAN GEMINI 2000 spectrometer DMSO-d 6 with tetramethylsilane as an internal standard. Elemental analyses were performed on CARlO ERBA STRuMENTAzIONE 1106 apparatus. IR spectra were recorded on FTIR-ATR REACT IR 1000 spectrometer in KBr. All solvents were distilled and dried appropriately prior to use. The course of the reactions were monitored by TlC in hexane / ethyl acetate (3:1) . Flash column chromatography was performed on SiO 2 (Merck Silica gel 60 F 254 ) with hexane / ethyl acetate (3:1) as eluent. All microwave assisted reactions were performed in an Initiator BIOTAGE microwave synthesizer.
4-Oxo-4H-chromene-3-carbaldehydes were synthesized according to the method described by Nohara [19] . 7-R 3 -Coumarin-3-acetic acids 2 were synthesized according to the method described in [20] . The other chemicals were purchased from the suppliers as the highest purity grade.
2.1.
5H-pyrano[3,2-c]chromen-5-yl acetates (3a-3m) 1251, 1189, 1159, 1120, 1043, 996, 919, 842 , 757 cm -1 . 1 H NMR (300 MHz, DMSO-d 6 ): 8.55 (s, 1 H, H-4'); 8.23 (s, 1 H, 7.80 (d, 1 H, J = 7.6 Hz, 7.66 (d, 1 H, J = 8.5 Hz, 7.59 (ddd, 1 H, J = 0.8, 7.2, 7.4 Hz, 7.36 (d, 1 H, J = 7.1 Hz, 7.35 (d, 1 H, J = 7.6 Hz, 7.34 (ddd, 1 H, J = 0.8, 7.2, 7.4 Hz, H-6'); 7.12 (ddd, 1 H, J = 0.9, 7.5, 8.0 Hz, 7.07 (d, 1 H, J = 7.9 Hz, H-7); 6.40 (s, 1 H, H-5); 1.98 (s, 3 H, AcO) . 13 C NMR (75 MHz, DMSO-d 6 ): 172. 7, 159.7, 159.4, 153.3, 153.0, 151.4, 142.5, 142.3, 132.7, 132.2, 128.7, 124.7, 122.7, 121.9, 120.5, 118.9, 118.3, 117.5, 116.0, 114.4, 109.0, 91.7, 21 .0.
9-Methyl-3-(2-oxo-2H-chromen-3-yl)-2-oxo-2H,5H-pyrano[3,2-c]chromen-5-yl acetate (3b). Method A, work-up as described above gave 69% (method B, 72%) of 3b, as yellow powder: m.p. 268-271°C (toluene). Anal. calcd. for C 24 H 16 O 7 (416.4): C, 69.23; H, 3.87. Found: C, 69.01; H, 3.89. IR (KBr): 3400, 3008, 2545 , 1718 , 1702 , 1620 , 1605 , 1564 , 1495 , 1368 , 1320 , 1285 , 1245 , 1190 , 1118 , 1050 : 197.4, 169.6, 159.9, 159.8, 153.7, 153.2, 150.6, 142.9, 141.7, 134.3, 133.1, 132.4, 128.9, 124.8, 119.9, 119.1, 118.2, 116.4, 113.6, 105.5, 89.9, 21.0, 20.7. 8,9-Dimethyl-3-(2-oxo-2H-chromen-3-yl)-2-oxo-2H,5H-pyrano[3,2-c]chromen-5-yl acetate (3c). Method A, work-up as described above gave 82% of 3c, as yellow powder: m.p. 276-278°C (toluene). Anal. calcd. for C 25 H 18 O 7 (430.4): C, 69.76; H, 4.22. Found: C, 69,58; H, 4.19. IR (KBr): 3380, 3065, 2969 , 1728 , 1650 , 1609 , 1552 , 1491 , 1460 , 1378 , 1324 , 1290 , 1249 , 1189 , 1159 , 1120 , 1045 3-(2-Oxo-2H-chromen-3-yl)-2-oxo-2H, 3353, 3057, 1730, 1655, 1608, 1550, 1497, 1377, 1285, 1190, 1162, 1120, 1045, 990, 921, 850 7.69 (ddd, 1 H, J = 0.9, 7.5, 7.9 Hz, 7.60 (d, 1 H, J = 7.5 Hz, 7.47 (d, 1 H, J = 7.7 Hz, 2 H, 6'); 7.35 (d, 1 H, J = 7.6 Hz, ; 6.45 (s, 1 H, H-5); 2.03 (s, 3 H, AcO). The 13 C NMR spectrum was non-measurable because of the low solubility of 3d.
9-Chloro-3-(2-oxo-2H-chromen-3-yl)-2-oxo-2H,5H-pyrano[3,2-c]chromen-5-yl acetate (3e). Method A, work-up as described above gave 80% of 3e, as yellow powder: m.p. 297-298°C (toluene). Anal. calcd. for C 23 H 13 ClO 7 (436.8): C, 63.24; H, 3.00; Cl, 8.12. Found C, 63.08; H, 3.03; Cl, 7.97. IR (KBr): 3350, 3070, 2970 , 1732 , 1654 , 1605 , 1552 , 1493 , 1460 , 1370 , 1285 , 1205 , 1185 , 1159 , 1120 , 1045 , 1005 3, 159.9, 159.2, 153.3, 151.5, 150.4, 143.4, 141.1, 133.0, 132.6, 129.0, 128.8, 124.9, 122.8, 119.5, 119.3, 119.1, 119.0, 116.3, 115.4, 106.2, 89.7, 20.9 .
9-Nitro-3-(2-oxo-2H-chromen-3-yl)-2-oxo-2H,5H-pyrano[3,2-c]chromen-5-yl acetate (3f). Method A, work-up as described above gave 85% (method B, 87%) of 3f, as yellow powder: m.p. 284-287°C (nitromethane). Anal. calcd. for C 23 H 13 NO 9 (447.4): C, 61.75; H, 2.93; N, 3.13. Found: C, 61.91; H, 2.94; N, 2.99. IR (KBr): 3395, 3065, 2976 , 1760 , 1705 , 1695 , 1655 , 1602 , 1581 , 1550 , 1501 , 1490 , 1437 , 1305 , 1245 , 1207 , 1198 , 1120 , 1090 , 1006 168.9, 159.8, 159.7, 156.2, 153.3, 150.5, 143.8, 143.4, 140.4, 132.8, 129.1, 127.9, 125.0, 120.4, 119.4, 119.1, 118.9, 118.5, 116.5, 114.6, 106.6, 89.7, 20.9 .
8-Acetyloxy-3-(2-oxo-2H-chromen-3-yl)-2-oxo-2H,5H-pyrano[3,2-c]chromen-5-yl acetate (3g). Method A, work-up as described above gave 71% (method B, 74%) of 3g, as yellow powder: m.p. 281-283°C (toluene). Anal. calcd. for C 25 H 16 O 9 (460.4): C, 65.22; H, 3.50. Found: 65.41; H, 3.53. IR (KBr): 2920 , 2865 , 1754 , 1720 , 1620 , 1555 , 1451 , 1485 , 1375 , 1324 , 1221 , 1190 , 1120 , 1085 , 1040 , 1014 8, 167.6, 159.4, 154.1, 150.4, 150.0, 145.8, 145.6, 143.0, 141.9, 132.3, 128.9, 124.8, 124.2, 119.2, 118.6, 118.3, 116.4, 116.0, 114.6, 111.4, 107.5, 92.3, 21.2, 20.9 .
9-Acetyloxy-3-(2-oxo-2H-chromen-3-yl)-2-oxo-2H,5H-pyrano [ 169.4, 160.0, 159.4, 153.2, 150.4, 145.7, 145.7, 143.2, 141.3, 132.4, 128.9, 124.8, 124.7, 120.5, 119.7, 119.1, 118.6, 118.5, 116.3, 116.1, 114.8, 106.7, 96.8, 20.9, 20.8. 7,8-Diacetyloxy-3-(2-oxo-2H-chromen-3-yl)-2-oxo-2H,5H-pyrano[3,2-c]chromen-5-yl acetate (3i). Method A, work-up as described above gave 69% of 3i, as yellow powder: m.p. 230-232°C (toluene). Anal. calcd. for C 27 H 18 O 11 (518.4): C, 62.55; H, 3.50. Found C, 62.37; H, 3.52. IR (KBr): 3105, 1760 , 1649 , 1600 , 1580 , 1505 , 1489 , 1401 , 1350 , 1302 , 1295 , 1244 , 1187 , 1150 , 1102 168.9, 168.2, 167.5, 158.9, 158.6, 152.9, 151.1, 146.1, 145.0, 143.1, 141.5, 132.7, 131.9, 128.9, 125.0, 121.1, 120.2, 118.6, 118.2, 116.1, 113.3, 105.2, 89.1, 20.9, 20.6, 19.9 .
3-Oxo-2-(2-oxo-2H-chromen-3-yl)-3H,12H-benzo[h]pyrano[3,2-c]chromen-12-yl acetate (3j).
Method A, work-up as described above gave 67% of 3j as yellow powder: m.p. 286-289°C (toluene). Anal. calcd. for C 27 H 16 O 7 (452.4): C, 71.68; H, 3.56. Found: 71.79; H, 3.54. IR (KBr):3386, 3065, 2950 , 1701 , 1699 , 1640 , 1617 , 1603 , 1520 , 1487 , 1410 , 1318 , 1250 , 1205 , 1197 , 1163 , 1110 , 1042 , 1012 3, 156.6, 159.3, 152.9, 152.3, 150.3, 142.4, 142.3, 135.4, 132.1, 128.7, 128.4, 127.9, 126.4, 124.7, 124.5, 122.6, 121.5, 120.8, 118.9, 118.4, 117.5, 115.9, 108.7, 107.9, 92.2, 20.7. 3-(7-Methoxy-2-oxo-2H-chromen-3-yl)-2-oxo-2H,5H-pyrano[3,2-c]chromen-5-yl acetate (3k). Method A, work-up as described above gave 81% of 3k as yellow powder: m.p. 294-296°C (toluene). Anal. calcd. for C 24 H 16 O 8 (432.4): C, 66.67; H, 3.73. Found: C, 66.82; H, 3.51. IR (KBr): 2958 , 2927 , 2858 , 1722 , 1645 , 1614 , 1552 , 1506 , 1460 , 1375 , 1259 , 1197 , 1159 , 1074 , 1020 1, 158.9, 158.6, 155.0, 151.7, 151.4, 143.2, 141.2, 133.4, 130.1, 123.5, 122.6, 120.1, 117.5, 117.3, 113.9, 113.0, 112.2, 105.4, 100.4, 89.2, 56.1, 20.7. 3-(7-Acetyloxy-2-oxo-2H-chromen-3-yl)-2-oxo-2H,5H-pyrano[3,2-c]chromen-5-yl acetate (3l). Method A, work-up as described above gave 65% of 3l as yellow powder: m.p. 239 -243°C. (nitromethane). Anal. calcd. for C 25 H 16 O 9 (460.4): C, 65.22; H, 3.50. Found: C, 65.43; H, 3.47. IR (KBr): 2929 , 2864 , 1760 , 1725 , 1617 , 1551 , 1455 , 1486 , 1378 , 1320 , 1196 , 1127 , 1046 , 1007 168.9, 168.6, 158.4, 158.3, 153.4, 153.2, 151.74, 151.72, 142.4, 141.7, 133.4, 129.8, 123.4, 122.6, 120.3, 119.6, 119.0, 117.4, 116.4, 113.8, 109.8, 105.3, 89.1, 20.8, 20.6 . 7, 168.9, 159.6, 159.2, 155.3, 153.2, 152.6, 151.5, 149.7, 143.0, 140.6, 132.3, 129.6, 121.9 and 121.9, 119.8, 117.4, 114.3, 113.1, 109.6, 109.1, 107.9, 96.7, 91.3, 20.9. 
3-[7-(N,N-Dimethylamino)-2-oxo-2H-chromen-3-yl]-2-oxo-2H,5H-pyrano[3,2-c]chromen-5-yl acetate (3m

2.2.
Method A: A solution of acetate 3 (10 mmol) and 4-methylbenzenesulfonic acid (8 mg, 0.04 mmol) in ethanol (10 ml) was stirred and heated at 60 o C for 3 h. After cooling, the formed solid compound was filtered off, washed with diethyl ether and re-crystallized from ethanol.
Method B: A solution of acetate 3 (10 mmol), appropriate alcohol (hexan-1-ol or prop-2-yn-1-ol) (10.5 mmol) and 4-methylbenzenesulfonic acid (8 mg, 0.04 mmol) in toluene (10 ml) was stirred and heated at 100 o C for 2 h. After cooling, the solid was filtered off, washed with diethyl ether and re-crystallized from toluene.
5-Ethoxy-9-methyl-3-(2-oxo-2H-chromen-3-yl)-2H,5H-pyrano[3,2-c]chromen-2-one (4a).
Method A, work-up as described above gave 72% of 4a as yellow powder: m.p. 189-191°C (ethanol 3089, 2940, 1705, 1698, 1641, 1545, 1495, 1460, 1402, 1327, 1264, 1212, 1151, 1129, 1090, 1017, 995, 908 3.58; Cl, 8.38. Found: C, 65.49; H, 3.55; Cl, 7.99. IR (KBr): 3090, 2935 , 1708 , 1701 , 1644 , 1555 , 1501 , 1468 , 1410 , 1325 , 1271 , 1220 , 1155 , 1137 , 1094 , 1020 7, 153.2, 151.5, 151.1, 143.1, 141.8, 132.6, 132.4, 129.0, 127.9, 124.8, 122.8, 119.6, 119.2, 119.0, 118.8, 116.3, 115.9, 108.2, 97.3, 64.8, 15.8 . 1, 143.0, 142.5, 133.6, 132.4, 131.2, 128.9, 124.8, 122.1, 121.2, 118.7, 117.4, 116.0, 114.0, 109.1, 91.1, 20.1. 3-(7-Methoxy-2-oxo-2H-chromen-3-yl)-9-methyl-5-(prop-2-yn-1-yloxy)-2H,5H-pyrano[3,2-c]chromen-2-one (4d). Method B, work-up as described above gave 68% of 4d as yellow powder: m.p. 3095, 2899, 1710, 1700, 1645, 1565, 1499, 1455, 1412, 1325, 1272, 1225, 1163, 1144, 1089, 1032, 984, 865, 748 162.4, 159.1, 158.9, 154.9, 152.8, 151.3, 151.1, 150.0, 142.9, 137.9, 132.1, 131.6, 130.1, 127.6, 122.1, 119.4, 117.6, 117.2, 114.2, 112.9, 112.3, 107.1, 100.4, 79.2, 78.0, 20.2. 
5-Hexyloxy-3-(2-oxo-2H-chromen-3-yl)-2H,5H-pyrano[3,2-c]chromen-2-one (4c
2.3.
Method A: Compound 3 or 4 (0.33 mmol) and catalytic amount of 4-methylbenzenesulfonic acid (5.6 mg, 0.033 mmol) was heated in 20 ml of dioxane-water (3:1) at 70°C for 1h. The solid product was cooled to room temperature, filtered off and re-crystallised from dioxane.
Method B: Compound 3l (0.14 mmol) was added into the solution of 96% H 2 SO 4 (3.25 ml), H 2 O (1.3 ml) and EtOH (1.95 ml) (5:3:2). The mixture was stirred at 20°C for 10 min. Then H 2 O (25 ml) was added and the yellow solution was stirred at 20°C for 5 h. The formed yellow precipitate was filtered off, washed with H 2 O and re-crystallized from dioxane.
5-Hydroxy-3-(2-oxo-2H-chromen-3-yl)-2H,5H-pyrano[3,2-c]chromen-2-one (5a). Method A, work-up as described above gave 71% of 5a as yellow powder: m.p. 283 -285°C (dioxane). Anal. calcd. for C 21 H 12 O 6 (360.3): C, 70,00; H, 3,36. Found: C, 70,24; H, 3,39. IR (KBr): 3498, 3080, 1705 , 1695 , 1630 , 1543 , 1495 , 1461 , 1400 , 1320 , 1264 , 1212 , 1150 , 1127 , 1085 , 1014 7, 152.8, 150.8, 142.6, 142.4, 132.7, 132.4, 132.2, 128.7, 124.8, 122.2, 122.0, 121.1, 119.0, 118.7, 118.6, 117.5, 115.2, 114.1, 108 .9, 91.1. 3 ). The 13 C NMR spectrum was non-measurable because of the low solubility of 5b.
5-Hydroxy-9-methyl-3-(2-oxo-2H-chromen-3-yl)-2H,5H-pyrano[3,2-c]chromen-2-one (5b
8,9-Dimethyl-5-hydroxy-3-(2-oxo-2H-chromen-3-yl)-2H,5H-pyrano[3,2-c]chromen-2-one (5c). Method
5-Hydroxy-3-(2-oxo-2H-chromen-3-yl)-2H,5H-pyrano[3,2-c]chromen-2-ones (5a-5f)
A, work-up as described above gave 69% of 5c as yellow powder: m.p. 198-200°C (dioxane 1, 154.8, 152.8, 150.5, 142.9, 141.9, 132.7, 130.1, 122.3, 122.1, 119.4, 117.6, 117.4, 114.3, 113.0, 112.3, 109.1, 100.4, 91 .2, 56.1.
5-Hydroxy-3-(7-acetyloxy-2-oxo-2H-chromen-3-yl)-2H,5H-pyrano[3,2-c]chromen-2-one (5e).
Method A, work-up as described above gave 64% of 5e as yellow powder: m.p. 284-286°C (dioxane). Anal. calcd. for C 23 H 14 O 8 (418.4): C, 66.03; H, 3.37. Found: C, 65.83; H, 3.09. IR (KBr): 3076, 2930 , 2864 , 1764 , 1725 , 1644 , 1617 , 1548 , 1494 , 1435 , 1374 , 1320 , 1193 , 1127 , 1004 7.19 (ddd, 1 H, J = 0.8, 7.8, 7.9 Hz, H-9); 7.14 (dd, 1 H, J = 0.8, 8.2 Hz, H-7); 6.45 (d, 1 H, J = 6.6 Hz, H-5); 2.33 (s, 3 H, AcO). The 13 C NMR spectrum was non-measurable because of the low solubility of 5e.
5-Hydroxy-3-[(7-(N,N-dimethylamino)-2-oxo-2H-chromen-3-yl]-2H,5H-pyrano[3,2-c]chromen-2-one (5f).
Method A, work-up as described above gave 62% of 5f as orange powder: m.p. 293-296°C (dioxane). Anal. calcd. for C 23 H 17 NO 6 (403.4): C, 68.48; H, 4.25; N, 3.47. Found: C, 68.22; H, 3.99; N, 3.21. IR (KBr): 1787 , 1718 , 1617 , 1594 , 1521 , 1463 , 1386 , 1301 , 1251 , 1208 , 1146 , 1062 , 1019 7, 159.4, 155.4, 153.3, 152.7, 149.7, 143.2, 140.79, 140.78, 132.46, 132.45, 129.8, 122.1, 122.0, 119.8, 117.6, 114.4, 113.1, 109.7, 109.2, 108.0, 96.7, 91.3 . 3630, 3283, 2974, 2935, 1707, 1614, 1552, 1498, 1460, 1375, 1321, 1243, 1204, 1158, 1128, 1043, 981, 903, 850, 811, 765 155.0, 152.8, 150.3, 143.2, 141.8, 132.7, 130.4, 122.2, 122.1, 119.6, 117.6, 116.3, 114.3, 113.7, 111.2, 109.1, 101.9, 91.2. 
5-hydroxy-3-(7-hydroxy-2-oxo-2H-chromen-3-yl)-2H,5H-pyrano[3,2-c]chromen-2-one (5g
2.4.
The solution of nitrogen containing compound (formamide, acetylamide, 4-methylphenylsulfonamide, ethyl carbamate or 1,3-oxazolidin-2-one) (10 mmol) in nitromethane (7 ml) was added to the solution of acetate 3 (10 mmol) in nitromethane (7 ml) in the presence of 4-methylbenzenesulfonic acid (15 mg, 0.075 mmol). The mixture was refluxed for 3 h. After cooling, the formed solid product was filtered off, washed with cold diethyl ether and re-crystallized from nitromethane. Cl, 8.41; N, 3.32. Found: C, 62.81; H, 2.91; Cl, 8.04; N, 3.49 = 8.4, 8.7, 8.7 Hz, CH 2 ); 3.47 (q, 1H, J = 3.9, 3.9, 4.8 Hz, CH 2 ); 3.19 (q, 1H, J = 8.7, 8.7, 8.9 Hz, CH 2 ); 2.35 (s, 3 H, CH 3 ). The 13 C NMR spectrum was unmeasurable because of the low solubility of 6f.
9-Chloro-5-(N-formylamino)-3-(2-oxo-2H-chromen-3-yl)-2H,5H-pyrano[3,2-c]chromen-2-one (6a
2.5.
Method A: Compound 3 (10 mmol) was dissolved in acetic acid (10 ml) and the solution was stirred at 60°C for 2-3 h. After cooling, the yellow precipitate was filtered off, washed with diethyl ether and re-crystallized from toluene.
Method B: Compound 3l or 5e (10 mmol) was dissolved in 30% sulphuric acid (40 ml) and the solution was stirred at 100°C for 10 h. Yellow-green precipitate was filtered off, washed with water, then washed with diethyl ether and re-crystallized from toluene.
7-Fluoro-5-hydroxy-3-(2-oxo-2H-chromen-3-yl) pyrano[2,3-b]chromen-2(10aH)-one (7a).
Method A, work-up as described above gave 70% of 7a as yellow powder: m.p. 295-298 °C (toluene). Anal. calcd. for C 21 H 11 FO 6 (378.3): C, 66.67; H, 2.93; F, 5.02. Found: C, 66.691; H, 3.04; F, 5.38. IR (KBr): 3024, 2905, 1705, 1675, 1599, 1550, 1500, 1480, 1332, 1304, 1255, 1187, 1165, 1052, 945, 899, 826, 801 cm -1 . 1 H NMR (300 MHz, DMSO-d 6 ): 8.49 (s, 1 H, H-4'); 8.12 (s, 1 H, H-4); 7.88 (brs, 1H, OH); 7.82 (dd, 1 H, J = 1.5, 7.8 Hz, H-5'); 7.68 (ddd, 1 H, J = 1.5, 7.2, 8.6 Hz, H-7'); 7.51 (d, 1H, J = 3.2 Hz, H-6); 7.49 (d, 1 H, J = 8. 8 Hz, 7.45 (ddd, 1 H, J = 0.9, 7.2, 7.8 Hz, 7.37 (dd, 1 H, J = 3.2, 8.8 Hz, 7.19 (dd, 1 H, J = 4.4, 8.9 Hz, H-9); 6.45 (s, 1 H, H-10a). 13 C NMR (75 MHz, DMSOd 6 ): 153. 1, 151.8, 150.3, 142.9, 142.1, 132.4, 132.2, 129.0, 128.8, 128.5, 126.9, 124.8, 122.2, 120.1, 119.1, 118.9, 116.2, 115.6, 109.6, 106.3, 91 .9.
7-Chloro-5-hydroxy-3-(2-oxo-2H-chromen-3-yl) pyrano[2,3-b]chromen-2(10aH)-one (7b).
Method A, work-up as described above gave 68% of 7a as yellow powder: m.p. 275 -277 °C (toluene). Anal. calcd. for C 21 H 11 ClO 6 (394.8): C, 63,89; H, 2,81; Cl, 8,98. Found: C, 64,13; H, 2,89; Cl, 9,31. IR (KBr): 3020, 2900 , 1705 , 1670 , 1600 , 1550 , 1499 , 1480 , 1330 , 1300 , 1255 , 1180 , 1164 , 1055 . 1 H NMR (300 MHz, DMSO-d 6 ): 8.47 (s, 1 H, H-4'); 8.11 (s, 1 H, H-4); 7.94 (brs, 1H, OH); 7.83 (dd, 1 H, J = 1.5, 7.9 Hz, H-5'); 7.69 (d, 1H, J = 2.6 Hz, H-6); 7.68 (ddd, 1 H, J = 1.5, 7.2, 8.8 Hz, 7.53 (dd, 1 H, J = 2.6, 8.7 Hz, 7.47 (dd, 1 H, J = 0.9, 8.8 Hz, ; 7.41 (ddd, 1 H, J = 0.9, 7.2, 7.9 Hz, H-6'); 7.18 (d, 1 H, J = 8.7 Hz, H-9); 6.48 (s, 1 H, H-10a). The 13 C NMR spectrum was nonmeasurable because of the low solubility of 7b.
5-Hydroxy-3-(7-hydroxy-2-oxo-2H-chromen-3-yl) pyrano[2,3-b]chromen-2(10aH)-one (7c). Method B, work-up as described above gave 75% of 7c as yellowgreen powder: m.p. 237 -239 °C (toluene). Anal. calcd. for C 21 H 12 O 7 (376.3): C, 67.02; H, 3.21. Found: C, 66.89; H, 3.02. IR (KBr): 3630,, 3599, 2927 , 2858 , 1715 , 1692 , 1614 , 1468 , 1359 , 1328 , 1228 , 1197 , 1159 , 1128 , 1027 7.85 (ddd, 1 H, J = 1.6, 7.1, 8.7 Hz, 7.70 (dd, 1 H, J = 1.0, 8.7 Hz, 7.63 (d, 1 H, J = 8.5 Hz, 7.54 (ddd, 1 H, J = 1.0, 7.1, 8.2 Hz, , 6.99 (d, 1 H, J = 1. 1 Hz, 6.84 (dd, 1 H, J = 2.3, 8.5 Hz, 6.77 (d, 1 H, J = 2.3 Hz, . 13 C NMR (75 MHz, 167.3, 161.6, 159.6, 155.7, 155.4, 155.1, 141.7, 134.4, 133.9, 130.2, 125.8, 125.7, 125.4, 123.2, 122.0, 120.3, 118.5, 113.6, 111.5, 101.9. 
Results and discussion
Synthesis of pyrano [3,2-c] chromen-2-one skeleton from azlactones or acrylates was already reported by Ghosh [21, 22] . chromen-3-yl)benzamides were prepared by heating of corresponding azlactones in the presence of pyridine [21] . Ethyl 5-ethoxy-2-oxo-2H,5H-pyrano [3,2-c] chromene-3-carboxylate was obtained by reaction of ethyl 2-cyano-3-(4-oxo-4H-chromen-3-yl)acrylate in . Among the condensations of coumarin-3-acetic acids only the reaction of 2 with furan-2-carbaldehydes was described [23] to obtain Perkin condensation products. Recently, we developed convenient synthesis of 2-oxo-2H,5H-pyrano [3,2-c] chromen-5-yl acetates 3 by heating equimolar quantities of chromene-3-carbaldehyde 1 and substituted acetic acids 2 in acetic anhydride in the presence of catalytic amount of sodium acetate or potassium carbonate [24, 25] .
3 -( 2 -O x o -2 H -c h r o m e n -3 -y l ) -2 -o x o -2 H , 5 Hpyrano [3,2-c] chromen-5-yl acetates 3 (Scheme 1) were isolated as the only products after 2 h of heating at 90-100ºC in high yields (56-85%). The isolation of acetates 3 from reaction mixtures was simple because they are formed as the first precipitates. Under these reaction conditions no traces of other products were found in the reaction mixtures according to the TlC and 1H-NMR analyse. Prolonged reaction time or increase in reaction temperature leads to a mixture of various byproducts [24] . Hydroxy-3-(2-oxo-2H-chromen-3-yl)  pyrano[2,3-b]chromen-2(10aH)-ones  (7a-7c) The mechanism, assumed for the formation of 3 involves the reaction of aldehydes 1 with the mixed in situ formed anhydride of acetic and coumarin-3-acetic acids 2 yielding acetylated aldol reaction intermediate A, which can exist in the form of pyrylium salt B. We proposed that the next step involves intramolecular nucleophilic attack of enolate anion from C-4 to the carboxylate C=O bond of B together with concomitant attack of acetate anion at C-2 position of pyrylium ring. Induced lactonisation as described above led to acetate 3. Compounds 3 were also isolated when the same reaction was carried out in a microwave oven. In this case the yields of 3 were comparable to those, obtained under conventional heating (72-87%), but the duration under microwave irradiation was considerably shorter (10 min) and obtained product 3 was pure enough ( 1 H NMR spectra) to be used for the next reaction without any further purification.
5-
The acetyloxy group at C-5 of acetates 3 easily undergoes nucleophilic substitution under acidic catalysis. Heating and stirring of 3 in ethanol in the presence of catalytic amount of 4-methylbenzenesulfonic acid for 3 h at 60°C yielded ethoxy derivatives 4a and 4b in 72 and 74% yields, respectively. In cases were the used alcohol is a solid or is expensive, it can be dissolved in toluene or nitrobenzene together with acetate 3 and 4-methylbenzenesulfonic acid. Heating of the reaction mixture at 100 o C for 2 h yielded derivatives 4c and 4d in 67 and 68% yields, respectively.
Compounds 3 or 4 can be converted to 5-hydroxy-3-(2-oxo-2H-chromen-3-yl)-2H,5H-pyrano [3,2-c] chromen-2-ones 5 in good yields (62-72%) by their heating at 70°C for 1h in dioxane-water media in the presence of catalytic amount of 4-methylbenzenesulfonic acid (Scheme 2).
Depending on the reaction media and temperature, 3-(7-acetyloxy-2-oxo-2H-chromen-3-yl)-2-oxo-2H,5H-pyrano [3,2-c] chromen-5-yl acetate 3l can give access to three different derivatives. When 3l was treated with 4-methylbenzenesulfonic acid in dioxane-water (3:1) at 70°C for 1h, only C-5 acetyl group is removed to give 5-hydroxy-3-(7-acetyloxy-2-oxo-2H-chromen-3-yl)-2H,5H-pyrano [3,2-c] chromen-2-one 5e. Both C-5 and C-7' acetyl groups were removed under stirring of 3l in the solution of 96% H 2 SO 4 , H 2 O and EtOH (5:3:2) for 10 min. The reaction temperature has to be kept under 20°C, because heating 3l in 30% H 2 SO 4 at elevated temperature (100°C) led to rearranged 5-hydroxy-3-(7-hydroxy-2-oxo-2H-chromen-3-yl)pyrano[2, 3-b] chromen-2(10aH)-one 7c.
Treatment of acetates 3 with nitrogen containing compound (formamide, acetylamide, 4-methylphenylsulfonamide, ethyl carbamate or 1,3-oxazolidin-2-one) in the presence of 4-methylbenzenesulfonic acid after 3h led to 5-R 4 -aminosubstituted 3-(2-oxo-2H-chromen-3-yl)-2H,5H-pyrano [3,2-c] chromen-2-ones 6 in 69-79% yields (Scheme 2). The mechanism, assumed for the formation of 4-6 involves the protonation of acetyloxy group of 3 (structure C) and cleavage of acetic acid led to the 2-oxo-2H-pyrano [3,2-c] chromen-6-ium D, which is further converted to product 4-6 by the addition of nucleophile (water, alcohol or nitrogen group) [25] .
Rearrangement of 5-substituted 3-(2-oxo-2H-chromen-3-yl)-2-oxo-2H,5H-pyrano[3,2-c]chromenes 3 or 5 to 5-hydroxy-3-(2-oxo-2H-chromen-3-yl) pyrano[2, 3-b] chromen-2(10aH)-ones 7 readily occurs in acidic media (e.g. by acetic or sulphuric acid) and elevated temperature. Formation of 7 can be explained by the protonation of 3 or 5 to give intermediate E. Addition of acetyloxy anion (or water) to the protonated E and the ring opening lead to structure F. The intramolecular rotation around single bond in the molecule F and a final 1,6-ring closure results derivatives 7 in 68-75 % yields (Scheme 3).
Compounds 3a, 3c, 3d, 3e, 3k, 3m, 4a, 4c, 5b, 5d, 5f and 5g were screened on their antineoplastic activity in NCI uSA. Substances 3c, 3d, 3e, 3k, 4a and 4c were The biological activity of 3a, 3m, 5b, 5d, 5f and 5g obtained from their antineoplastic screening on 60 cancer cell lines at NCI USA. The results represent concentration of compounds that are necessary to slow down the human tumor cells proliferation to half (GI 50 ) in average for all 60 cell lines (the 2 nd column) or in the best cases for particular cancer cell lines (the 3rd column).
not active enough to be selected for the next screening. Compounds 3a, 3m, 5b, 5d, 5f and 5g were tested on 60 human cancer cell lines panel at 5 concentrations (from 10 -4 M to 10 -8 M). The most interesting results are depicted in Table 1 .
Conclusions
3-(2-Oxo-2H-chromen-3-yl)-2-oxo-2H,5H-pyrano [3,2-c] chromen-5-yl acetates 3 were synthesized by reaction of 4-oxo-4H-chromen-3-carbaldehydes 1 with coumarin-3-acetic acids 2 in acetic anhydride in the presence of sodium acetate. Reaction of 3 with alcohols gave corresponding 5-alkoxy-3-(2-oxo-2H-chromen-3-yl)-2H,5H-pyrano [3,2-c] chromen-2-ones 4 by two ways. Either acetate 3 reacted with excess of ethanol in the presence of 4-methylbenzenesulfonic acid at mild conditions, or the reaction of 3 with alcohol (hexan-1-ol or prop-2-yn-1-ol) was carried out in toluene under acidic catalysis. Synthesis of some derivatives 4 was accelerated under microwave irradiation and completed within 10 min. Similarly, acid catalyzed reaction of acetates 3 with water yielded 5-hydroxy-3-(2-oxo-2H-chromen-3-yl)-2H,5H-pyrano [3,2-c] chromen-2-ones 5. Reaction of 3 with nitrogen containing compound (formamide, acetylamide, 4-methylphenylsulfonamide, ethyl carbamate or 1,3-oxazolidin-2-one) gave 5-R 4 -aminosubstituted 2H,5H-pyrano [3,2-c] chromen-2-ones 6. Derivatives 3 or 5 readily rearrange to 5-hydroxypyrano[2, 3-b] chromen-2(10aH)-ones 7 under acid catalysis at elevated temperature.
Twelve prepared compounds were under antineoplastic activity evaluation. Six of them 3a, 3m, 5b, 5d, 5f and 5g passed pre-screening selection procedure and were further tested at different concentrations (from 10 -4 M to 10 -8 M) on 60 human tumor cell line panel at NCI uSA. According the results from Table 1 , we can conclude that all six screened compounds were able to slow down human cancer cells proliferation at micromolar concentration. For compound 5d in one particular case (CNS Cancer / SF-295) GI 50 activity was stated to be better as 10 nM. In this case a validation of this activity would be necessary to exclude possible false positive result. Even though the compound 3m has the lowest average GI 50 value, in one cell line (leukemia / RPMI-8226) GI 50 reaches the interesting concentration of 390 nM. Among all screened substances the compound 5f has the most effective antineoplastic properties for both the average GI 50 value (obtained through all 60 screened human cancer cell lines) and also for several particular cell lines where GI 50 activities of 5f were obtained at submicromolar concentrations. Based on the biological results substances possessing 3-(2-oxo-2H-chromen-3-yl)-2-oxo-2H,5H-pyrano [3,2-c] chromene skeleton are promising compounds with potential antineoplastic properties. Further structure activity relationship research is required in order to improve their antitumor activity.
